Eterna Therapeutics
ERNA
#9573
Rank
ยฃ21.22 M
Marketcap
ยฃ0.41
Share price
-2.29%
Change (1 day)
-47.15%
Change (1 year)

Revenue for Eterna Therapeutics (ERNA)

Revenue in 2024 (TTM): ยฃ0.12 Million

According to Eterna Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ0.12 Million. In 2023 the company made a revenue of ยฃ0.05 Million an increase over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Eterna Therapeutics from 2020 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ0.12 M142.68%
2023 ยฃ0.05 M
2022 N/A
2021 N/A
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ11.91 B 9,257,307.41%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.09 M 747.53%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ42.51 B 33,028,997.80%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ0.92 B 715,369.14%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ13.59 M 10,457.32%๐Ÿ‡ฆ๐Ÿ‡บ Australia
ยฃ12.94 B 10,055,455.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel